- Home
- / Fluicell
Fluicell
Stock Price
KR0.1
2024-10-29
Market Capitalization
KR34.3 M
2024-10-29
Revenue
KR6 M
FY, 2025
Fluicell Summary
Company Summary
- Overview
- Fluicell is a company that specializes in developing microfluidic bioprinting technology. It offers Nexocyte, a tissue engineering platform for regenerative medicine and drug development. The company also provides single-cell research tools BioPen, Biozone 6, and Dynaflow Resolve.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- Mölndal, SE | view all locations
- Website
- https://www.fluicell.com/
- Cybersecurity rating
Table of Contents
Key People
Stefan Tilk, Chairman of the Board
Gavin D. M. Jeffries, Chief Technology Officer & Director
Tatsiana Lobovkina, Chief Scientific Officer
LocationsView all
1 location detected
Mölndal, Västra Götalands län HQ
Sweden
Flöjelbergsgatan 8C
Fluicell Financials
Summary Financials
- Revenue (FY, 2025)
- kr6.0M
- Gross profit (FY, 2025)
- kr4.2M
- Net income (FY, 2025)
- (kr8.3M)
- Cash (FY, 2025)
- kr2.3M
- EBIT (FY, 2025)
- (kr8.4M)